A detailed history of Alliancebernstein L.P. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Alliancebernstein L.P. holds 3,906,150 shares of BMY stock, worth $224 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,906,150
Previous 3,745,255 4.3%
Holding current value
$224 Million
Previous $156 Million 29.96%
% of portfolio
0.07%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $6.38 Million - $8.33 Million
160,895 Added 4.3%
3,906,150 $202 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $24 Million - $31.6 Million
-597,124 Reduced 13.75%
3,745,255 $156 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $16.3 Million - $18.5 Million
339,501 Added 8.48%
4,342,379 $235 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $27.7 Million - $33.1 Million
-571,400 Reduced 12.49%
4,002,878 $205 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $8.31 Million - $9.3 Million
-143,623 Reduced 3.04%
4,574,278 $265 Million
Q2 2023

Aug 15, 2023

BUY
$63.71 - $70.74 $24.8 Million - $27.6 Million
389,729 Added 9.0%
4,717,901 $302 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $86.9 Million - $98.6 Million
1,323,195 Added 44.03%
4,328,172 $300 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $20 Million - $23.6 Million
291,333 Added 10.74%
3,004,977 $216 Million
Q3 2022

Nov 15, 2022

BUY
$0.13 - $76.84 $6,047 - $3.57 Million
46,516 Added 1.74%
2,713,644 $193 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $964,829 - $1.06 Million
-13,286 Reduced 0.5%
2,667,128 $205 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $6.18 Million - $7.41 Million
-100,505 Reduced 3.61%
2,680,414 $196 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $3.71 Million - $4.33 Million
-69,252 Reduced 2.43%
2,780,919 $173 Million
Q3 2021

Nov 10, 2021

SELL
$59.17 - $69.31 $22 Million - $25.8 Million
-371,975 Reduced 11.54%
2,850,171 $169 Million
Q2 2021

Jul 30, 2021

SELL
$61.91 - $67.42 $99.8 Million - $109 Million
-1,611,524 Reduced 33.34%
3,222,146 $215 Million
Q1 2021

May 06, 2021

BUY
$59.34 - $66.74 $41.6 Million - $46.8 Million
700,700 Added 16.95%
4,833,670 $305 Million
Q4 2020

Feb 08, 2021

SELL
$57.74 - $65.43 $42.9 Million - $48.6 Million
-742,362 Reduced 15.23%
4,132,970 $256 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $42.2 Million - $46.7 Million
-734,402 Reduced 13.09%
4,875,332 $294 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $1.91 Million - $2.23 Million
34,795 Added 0.62%
5,609,734 $330 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $5.42 Million - $7.88 Million
-116,884 Reduced 2.05%
5,574,939 $311 Million
Q4 2019

Feb 18, 2020

BUY
$49.21 - $64.19 $51.8 Million - $67.5 Million
1,052,064 Added 22.67%
5,691,823 $365 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $7.09 Million - $8.4 Million
-165,740 Reduced 3.45%
4,639,759 $235 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $14.1 Million - $15.6 Million
316,326 Added 7.05%
4,805,499 $218 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $31.3 Million - $37.4 Million
694,362 Added 18.3%
4,489,173 $214 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $4.48 Million - $5.8 Million
-91,784 Reduced 2.36%
3,794,811 $197 Million
Q3 2018

Nov 08, 2018

BUY
$55.19 - $62.25 $3.12 Million - $3.52 Million
56,474 Added 1.47%
3,886,595 $241 Million
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $31.6 Million - $39.4 Million
-626,155 Reduced 14.05%
3,830,121 $212 Million
Q1 2018

May 14, 2018

BUY
$59.92 - $68.98 $95.5 Million - $110 Million
1,593,034 Added 55.64%
4,456,276 $282 Million
Q4 2017

Feb 13, 2018

SELL
$59.94 - $65.35 $14,445 - $15,749
-241 Reduced 0.01%
2,863,242 $175 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $158 Million - $183 Million
2,863,483
2,863,483 $183 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.